| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-07 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-06 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |